Abbott Laboratories
Held by 24 tracked managers as of Q2 2026 · CUSIP ⓘCUSIP: A 9-character ID for one specific security - one share class of one company, or one bond. Tickers can change and can mean different things in different countries; a CUSIP always identifies exactly the same security, which is why filings use it. Guide 002824100 · Sector ⓘGICS sectors: The 11-sector system most investors know (Global Industry Classification Standard): Technology, Health Care, Financials and so on. This site assigns each company a GICS-style sector from its SIC code, with a few hand corrections, so sector pages match the names investors expect. Guide
In plain English: 24 of the investors we track own this stock. In the latest quarter, 8 of them bought more of it and 12 sold some or all of theirs (4 bought it for the first time). That tells you what they did last quarter — not what the stock will do next.
Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer
Managers holding
24
+3 vs last quarter (like-for-like)
Total value held
$6.18B
Across tracked managers
Average weight ⓘOn average, how big this stock is in the portfolios that own it (its share of each manager's reported portfolio value).
0.6%
Of each manager's book
QoQ value ⓘLike-for-like: only managers that filed both quarters are compared, so a manager filing late (or confidentially) does not look like buying or selling. Includes price changes.
+$628.74M
+18.3% vs last quarter
Net shares bought
+11.3M
Est. net flow +$1.03B
Quarter activity
8 bought · 12 sold
4 new · 1 sold out
Tracked capital in this stock
Total value held (area) and number of managers (line). Dips can mean a large holder filed that quarter confidentially (e.g. Norges Bank in Q1/Q3).
Aggregate buying and selling
Net share change reported each quarter
Who owns ABT?
🔒 The 'who added and who trimmed' chart is a Plus feature
You're viewing the Free plan. Upgrade to unlock The 'who added and who trimmed' chart — every paid plan starts with a 7-day free trial, and you can cancel in two clicks.
Who owns ABT? — Q2 2026
Holders ranked by position size, with each one's quarter-over-quarter change.
Column filters
| # | Manager | Fund | Shares ↑ | Value | % of their portfolio | QoQ | Δ shares | Δ shares % | Est. Δ value ⓘChange in shares × this quarter's price |
|---|---|---|---|---|---|---|---|---|---|
| 24 | Polen Capital | Polen Capital Management | 3.16K | $286.38K | 0.0% | Reduced | -11.9K | -79.1% | -$1.08M |
| 23 | LSV Asset Management | LSV Asset Management | 3.23K | $293.00K | 0.0% | Held | 0 | 0.0% | $0 |
| 22 | First Wilshire | First Wilshire Securities Management | 3.48K | $315.32K | 0.1% | Held | 0 | 0.0% | $0 |
| 21 | John Ciampaglia & Eric Sprott | Sprott Inc | 6.96K | $632.00K | 0.0% | New | +7.0K | — | +$632.00K |
| 20 | Boston Partners | Boston Partners Global Investors | 8.34K | $755.96K | 0.0% | Reduced | -8.0K | -49.0% | -$727.04K |
| 19 | Dodge & Cox | Dodge & Cox | 17.32K | $1.57M | 0.0% | Held | 0 | 0.0% | $0 |
| 18 | Mario Gabelli | GAMCO Investors | 21.67K | $1.97M | 0.0% | Reduced | -897 | -4.0% | -$81.39K |
| 17 | Beutel Goodman | Beutel, Goodman & Co | 23.67K | $2.15M | 0.0% | Reduced | -900 | -3.7% | -$81.63K |
| 16 | George Soros | Soros Fund Management | 44.75K | $4.06M | 0.1% | Held | 0 | 0.0% | $0 |
| 15 | Ray Dalio | Bridgewater Associates | 59.77K | $5.42M | 0.0% | Reduced | -57.3K | -48.9% | -$5.20M |
| 14 | Ken Fisher | Fisher Asset Management | 505.42K | $45.86M | 0.0% | Reduced | -246.7K | -32.8% | -$22.38M |
| 13 | Parnassus Investments | Parnassus Investments LLC | 650.63K | $59.04M | 0.2% | Added | +11.3K | +1.8% | +$1.02M |
| 12 | Jim Simons | Renaissance Technologies | 686.37K | $62.28M | 0.1% | Reduced | -552.3K | -44.6% | -$50.12M |
| 11 | Mason Hawkins | Southeastern Asset Management (Longleaf) | 840.75K | $76.29M | 4.0% | New | +840.7K | — | +$76.29M |
| 10 | Mawer | Mawer Investment Management | 1.19M | $107.68M | 0.7% | Reduced | -67.0K | -5.3% | -$6.08M |
| 9 | David Shaw | D.E. Shaw & Co. | 1.46M | $132.26M | 0.1% | Reduced | -3.8M | -72.4% | -$346.85M |
| 8 | Steve Cohen | Point72 Asset Management | 1.55M | $140.82M | 0.2% | New | +1.6M | — | +$140.82M |
| 7 | Barrow Hanley | Barrow Hanley Mewhinney & Strauss | 3.57M | $324.05M | 1.0% | New | +3.6M | — | +$324.05M |
| 6 | Israel Englander | Millennium Management | 3.60M | $326.66M | 0.2% | Added | +2.3M | +172.0% | +$206.58M |
| 5 | Diamond Hill | Diamond Hill Capital Management | 4.94M | $447.96M | 3.6% | Reduced | -442.1K | -8.2% | -$40.11M |
| 4 | Two Sigma | Two Sigma Investments | 8.13M | $737.38M | 0.6% | Added | +1.7M | +27.2% | +$157.66M |
| 3 | Ken Griffin | Citadel Advisors | 8.60M | $780.11M | 0.4% | Added | +6.7M | +348.7% | +$606.27M |
| 2 | Jeremy Grantham | GMO | 8.79M | $797.97M | 1.8% | Reduced | -116.9K | -1.3% | -$10.60M |
| 1 | Norges Bank | Norges Bank Investment Management | 23.35M | $2.12B | 0.2% | — | — | — | — |
Column filters
| Manager | Fund | Shares sold | Value last quarter ↓ |
|---|---|---|---|
| Fred Alger | Fred Alger Management | -33.6K | $3.45M |
Politician trades
Column filters
| Politician | Date | Ticker | Asset | Type | Reported range ⓘThe dollar range the politician reported. Exact amounts are not disclosed. | Est. size ⓘOur estimate only: the midpoint of the reported range. | Owner | Account ⓘSubholding Of: the account the trade was in, as named on the report (e.g. an IRA or a brokerage account). The same stock bought on the same day in different accounts is a separate trade in each account. | Filed ↓ | Filing delay ⓘDays between the trade and the report. Over 45 days is late under the STOCK Act. | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Thomas H. Kean, Jr. Politician | Sep 17, 2026 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Kean Family Partnership | Oct 30, 2026 | 43 days | PTR ↗ |
| Pete Sessions Politician | Oct 2, 2026 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Sale | $50,001 - $100,000 | Est. $75,000 (midpoint of reported range $50,001–$100,000) | Spouse | Trust One | Oct 27, 2026 | 25 days | PTR ↗ |
| Rick W. Allen Politician | Jul 14, 2026 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | LIVTR | Aug 18, 2026 | 35 days | PTR ↗ |
| Richard McCormick Politician | Jul 30, 2026 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Growth Partners Roth IRA | Aug 14, 2026 | 15 days | PTR ↗ |
| Mike Kelly Politician | Jul 17, 2026 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Victoria Kelly Trust ICA | Aug 12, 2026 | 26 days | PTR ↗ |
| Richard McCormick Politician | Jun 12, 2026 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Growth Partners IRA | Jul 9, 2026 | 27 days | PTR ↗ |
| Richard McCormick Politician | Jun 12, 2026 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Growth Partners Roth IRA | Jul 9, 2026 | 27 days | PTR ↗ |
| Rick W. Allen Politician | Apr 16, 2026 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | R.W. Allen & Associates, Inc. > RWA&A - Securities | Jun 5, 2026 | 50 days Late | PTR ↗ |
| Richard McCormick Politician | Mar 19, 2026 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Growth Partners IRA | Apr 7, 2026 | 19 days | PTR ↗ |
| Michael T. McCaul Politician | Feb 5, 2026 | ABT | ABBOTT LABORATORIES scanned | Purchase | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | — | Mar 10, 2026 | 33 days | PTR ↗ |
| Michael T. McCaul Politician | Feb 27, 2026 | ABT | ABBOTT LABORATORIES on scanned | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | — | Mar 10, 2026 | 11 days | PTR ↗ |
| Thomas H. Kean, Jr. Politician | Jan 29, 2026 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Kean Family Partnership | Feb 19, 2026 | 21 days | PTR ↗ |
| Julia Letlow Politician | Oct 23, 2024 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Merrill Lynch Investment Account #025 | Jan 13, 2026 | 447 days Late | PTR ↗ |
| Julia Letlow Politician | Dec 8, 2025 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Merrill Lynch Investment Account #025 | Jan 13, 2026 | 36 days | PTR ↗ |
| Byron Donalds Politician | Dec 4, 2025 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Moran Wealth IRA | Jan 7, 2026 | 34 days | PTR ↗ |
| Byron Donalds Politician | Dec 4, 2025 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Moran Wealth IRA | Jan 7, 2026 | 34 days | PTR ↗ |
| Richard McCormick Politician | Nov 5, 2025 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | — | Dec 9, 2025 | 34 days | PTR ↗ |
| Richard McCormick Politician | Mar 15, 2023 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Growth Partners Roth IRA | Sep 17, 2025 | 917 days Late | PTR ↗ |
| Thomas H. Kean, Jr. Politician | Jul 21, 2025 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Kean Family Partnership | Aug 20, 2025 | 30 days | PTR ↗ |
| Lisa McClain Politician | Jun 24, 2025 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Aug 13, 2025 | 50 days Late | PTR ↗ |
| Lisa McClain Politician | Jul 10, 2025 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Aug 13, 2025 | 34 days | PTR ↗ |
| Jefferson Shreve Politician | May 12, 2025 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Sale | $50,001 - $100,000 | Est. $75,000 (midpoint of reported range $50,001–$100,000) | Self | CRT - Standard Unit Trust | Jun 22, 2025 | 41 days | PTR ↗ |
| Bruce Westerman Politician | Apr 21, 2025 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Fisher IRA | May 12, 2025 | 21 days | PTR ↗ |
| Bruce Westerman Politician | Mar 3, 2025 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Fisher IRA | Apr 16, 2025 | 44 days | PTR ↗ |
| Byron Donalds Politician | Mar 20, 2025 | ABT | Abbott Laboratories Common Stock (ABT) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Moran Wealth IRA | Apr 14, 2025 | 25 days | PTR ↗ |